Sichuan Province Trial Confirms Truscreen Technology

• Second phase of national clinical trial in Sichuan Province reported outstanding results

• Conducted by China Obstetrics and Gynaecology Association (COGA) a peak gynaecology body in China.

• Trial conducted across 14 hospitals with 1,243 patients participating

• Both sensitivity and specificity targeting pre-cancerous and cancerous cervical cells performed in aggregate better than other screening methods (see below table)

Truscreen Group Limited (NZX: TRU ) (Truscreen or Company) is pleased to advise results from The China Obstetrics and Gynaecology Association (COGA) ongoing national clinical trial that will screen over 20,000 women in 100 top-tier public hospitals across 10 provinces in China. The COGA evaluation compares the TruScreen technology to Liquid Based Cytology (LBC), and HPV DNA testing (HPV) and targets a nationwide consensus on Truscreen technology application in China as the main outcome of this large-scale trial.

See the link below for more details:

Sichuan Province Trial Confirms Truscreen Technology

Source: Truscreen Group Limited

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

MKR - High Grade Gold Drill Intersections from Pipeline Ridge
KMD - ASM Date and Closing Date for Director Nominations
PCT - Sale of PwC Tower now unconditional
GEN - General Capital (GEN:NZ) Subsidiary General Finance Update
BRW - Bremworth Director Resignations
September 10th Morning Report
PLP - Appointment of new director
BIF - appointment of new director
ERD - Ongoing Disclosure Notice - Directors Fixed Trading Plan
TEM - Transaction in Own Shares